4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-21-025783
President & CEO acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| USMAN NASSIM President & CEO | 2021-04-05 | Option exercise | +5,000 | $4.63 | $23,150 | 17,174 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| USMAN NASSIM President & CEO | 2021-04-05 | Option exercise · Stock Option (Right to Buy) | −5,000 | 259,783 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…